Ionis and Sobi’s Tryngolza gains approval in EU to treat FCS
Sobi holds exclusive rights to market Tryngolza outside the US, Canada and China. Credit: Swedish Orphan Biovitrum AB.…
‘No-go’ zones to be created in overhaul of environment laws
“No-go” zones where development will “simply not be allowed” will be created in the overhaul of Australia’s environment…
FDA clears Ensoma’s application for rare genetic disorder treatment
CGD patients often suffer from severe, recurrent bacterial and fungal infections. Credit: sergey kolesnikov / Shutterstock. The US…